Journal article 605 views 92 downloads
Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials
Vanita R. Aroda,
Matthew S. Capehorn,
Louis Chaykin,
Juan P. Frias,
Nanna L. Lausvig,
Stanislava Macura,
Jörg Lüdemann,
Sten Madsbad,
Julio Rosenstock,
Omur Tabak,
Sayeh Tadayon,
Steve Bain 
Diabetes, Obesity and Metabolism, Volume: 22, Issue: 3, Pages: 303 - 314
Swansea University Author:
Steve Bain
-
PDF | Accepted Manuscript
Download (404.27KB)
DOI (Published version): 10.1111/dom.13896
Abstract
Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials
| Published in: | Diabetes, Obesity and Metabolism |
|---|---|
| ISSN: | 1462-8902 1463-1326 |
| Published: |
Wiley
2020
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa52246 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
3 |
| Start Page: |
303 |
| End Page: |
314 |